title: The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder.
authors.forename: Gabriel
authors.initials: G
authors.lastname: Rubio
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Jiménez-Arriero
authors.forename: Isabel
authors.initials: I
authors.lastname: Martínez-Gras
authors.forename: Jorge
authors.initials: J
authors.lastname: Manzanares
authors.forename: Tomás
authors.initials: T
authors.lastname: Palomo
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D005632:Fructose / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D000077236:Topiramate
chemical_list: D000928:Antidepressive Agents; D018696:Neuroprotective Agents; D000077236:Topiramate; D005632:Fructose